Literature DB >> 33338422

A Crisp(r) New Perspective on SARS-CoV-2 Biology.

Adam L Bailey1, Michael S Diamond2.   

Abstract

Complementary genome-wide CRISPR-Cas9 screens performed by multiple groups reveal new insights into SARS-CoV-2 biology including aspects of viral entry, translation, replication, egress, and the genes regulating these processes. Comparisons with other coronaviruses enhances our understanding of the cellular life cycle of this medically important family of emerging viruses.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID： 33338422     DOI： 10.1016/j.cell.2020.12.003

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


  21 in total

Review 1.  SARS-CoV-2 pathogenesis.

Authors:  Mart M Lamers; Bart L Haagmans
Journal:  Nat Rev Microbiol       Date:  2022-03-30       Impact factor: 60.633

2.  An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies.

Authors:  Laura VanBlargan; John Errico; Peter Halfmann; Seth Zost; James Crowe; Lisa Purcell; Yoshihiro Kawaoka; Davide Corti; Daved Fremont; Michael Diamond
Journal:  Res Sq       Date:  2021-12-27

3.  A CRISPR Landing for Genome Rewriting at Locus-Scale.

Authors:  Nicholas W Hughes; Le Cong
Journal:  CRISPR J       Date:  2021-04

4.  Human airway cells prevent SARS-CoV-2 multibasic cleavage site cell culture adaptation.

Authors:  Mart M Lamers; Anna Z Mykytyn; Tim I Breugem; Yiquan Wang; Douglas C Wu; Samra Riesebosch; Petra B van den Doel; Debby Schipper; Theo Bestebroer; Nicholas C Wu; Bart L Haagmans
Journal:  Elife       Date:  2021-04-09       Impact factor: 8.140

5.  In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains.

Authors:  Michael Diamond; Rita Chen; Emma Winkler; James Case; Ishmael Aziati; Traci Bricker; Astha Joshi; Tamarand Darling; Baoling Ying; John Errico; Swathi Shrihari; Laura VanBlargan; Xuping Xie; Pavlo Gilchuk; Seth Zost; Lindsay Droit; Zhuoming Liu; Spencer Stumpf; David Wang; Scott Handley; W Stine; Pei-Yong Shi; Miguel Garcia-Knight; Raul Andino; Charles Chiu; Ali Ellebedy; Daved Fremont; Sean Whelan; James Crowe; Lisa Purcell; Davide Corti; Andrianus Boon
Journal:  Res Sq       Date:  2021-04-23

Review 6.  Innate immunity: the first line of defense against SARS-CoV-2.

Authors:  Michael S Diamond; Thirumala-Devi Kanneganti
Journal:  Nat Immunol       Date:  2022-02-01       Impact factor: 31.250

7.  SARS-CoV-2 variants show resistance to neutralization by many monoclonal and serum-derived polyclonal antibodies.

Authors:  Michael Diamond; Rita Chen; Xuping Xie; James Case; Xianwen Zhang; Laura VanBlargan; Yang Liu; Jianying Liu; John Errico; Emma Winkler; Naveenchandra Suryadevara; Stephen Tahan; Jackson Turner; Wooseob Kim; Aaron Schmitz; Mahima Thapa; David Wang; Andrianus Boon; Dora Pinto; Rachel Presti; Jane O'Halloran; Alfred Kim; Parakkal Deepak; Daved Fremont; Davide Corti; Herbert Virgin; James Crowe; Lindsay Droit; Ali Ellebedy; Pei-Yong Shi; Pavlo Gilchuk
Journal:  Res Sq       Date:  2021-02-10

8.  Genome-scale CRISPR screens identify host factors that promote human coronavirus infection.

Authors:  Marco Grodzki; Andrew P Bluhm; Moritz Schaefer; Abderrahmane Tagmount; Max Russo; Amin Sobh; Roya Rafiee; Chris D Vulpe; Stephanie M Karst; Michael H Norris
Journal:  Genome Med       Date:  2022-01-27       Impact factor: 11.117

9.  Observation on China's Strategies to Prevent the Resurgence of the COVID-19 Epidemic.

Authors:  Xiang Yu; Na Li; Yupeng Dong
Journal:  Risk Manag Healthc Policy       Date:  2021-05-18

10.  An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies.

Authors:  Laura A VanBlargan; John M Errico; Peter J Halfmann; Seth J Zost; James E Crowe; Lisa A Purcell; Yoshihiro Kawaoka; Davide Corti; Daved H Fremont; Michael S Diamond
Journal:  Nat Med       Date:  2022-01-19       Impact factor: 87.241
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.